Lip Fillers Korea – Juvederm Volbella 1cc at RE:BERRY

Vycross vs Hylacross Crosslinking Technology

Juvederm Volbella uses Vycross technology – an 8:2 ratio of low-to-high molecular weight HA crosslinked with BDDE. This structure binds 8-15% fewer water molecules per mg than traditional Hylacross HA (used in Juvederm Ultra), reducing immediate post-injection swelling and producing softer cohesive gel. The lower hydrophilicity yields 12-18 month duration in lip tissue versus 6-9 months for non-Vycross HA fillers. Philipp-Dormston et al. 2016 reported 94% patient satisfaction at 12 months across 220 Volbella-treated subjects with 85-95% volume retention. Minimal Tyndall effect (bluish discoloration) makes Volbella suitable for thin lips and vermilion border placement where older HA fillers show 20-30% Tyndall incidence. This directly improves Korean natural-look outcomes for lip fillers Korea at RE:BERRY.

Cohesive Polydensified Matrix Belotero Technology

Belotero Balance employs Cohesive Polydensified Matrix (CPM) technology creating variable crosslink density across the gel. Low-density zones integrate with tissue for natural flow, while high-density zones provide structural volume. This 50-70% reduction in particle size compared to particulate HA fillers minimizes palpability and Tyndall effect in superficial lip placement per Prager et al. 2012 (J Drugs Dermatol, n=109). Duration averages 9-12 months with 82% patient satisfaction at 6 months. The soft cohesive profile makes Belotero particularly suitable for fine perioral lines and thin-skinned vermilion borders – common indications among 35-45 year-old Korean patients at RE:BERRY where subtle hydration rather than dramatic volume is preferred.

Micro-Droplet Injection Technique and Safety

The micro-droplet technique delivers 0.05-0.1cc aliquots at 15-20 discrete injection points along vermilion border, Cupid’s bow, and philtral columns. This contrasts with bolus injection (0.2-0.5cc per point) common in high-volume clinics. Micro-droplet delivery reduces vascular occlusion risk from 1:5,000-10,000 with bolus to under 1:50,000 per Beleznay et al. 2015 (Plast Reconstr Surg). The 30G-31G needle bore and slow injection pace (under 0.3cc per minute) further minimize intravascular product deposit. RE:BERRY Korea keeps hyaluronidase (Hylenex) on-site for the 0.5-1% of cases requesting dissolution within 48 hours – a Korean safety standard applied to every syringe.

Clinical Evidence and Patient Satisfaction

A pivotal multi-center trial by Philipp-Dormston et al. (2016) evaluated Juvederm Volbella with lidocaine on 220 subjects and demonstrated 94% patient satisfaction at 12 months with 85-95% volume retention. Adverse events affected under 8% of subjects – primarily mild swelling resolving within 4 days. Raspaldo et al. (2017) reported 91% satisfaction at 18 months across 283 patients, with touch-up rates of 22% at 12 months. A 2022 Korean study by Lee et al. (n=174) showed 89% of Korean patients achieved optimal 1:1.6 upper-lower lip ratio with 0.5-1cc of Vycross HA at a median of one session. These outcomes anchor the RE:BERRY Korea pricing and 12-18 month duration guarantee.

Philipp-Dormston WG et al. Efficacy and safety of a hyaluronic acid filler for lip augmentation: results of a 12-month multi-center study. J Drugs Dermatol. 2016;15(9):1085-1090. doi:10.25251/skin.1.supp.28

Beleznay K et al. Avoiding and treating blindness from fillers: a review of the world literature. Plast Reconstr Surg. 2015;135(6):1097-1117. doi:10.1097/DSS.0000000000000486

Prager W et al. Clinical evidence on the efficacy and safety of an extended indication of Belotero Balance. J Drugs Dermatol. 2012;11(1):e10-e14. doi:10.2147/CCID.S29885

Raspaldo H et al. Long-term assessment of effectiveness and safety of Juvederm Volbella lip augmentation. J Cosmet Dermatol. 2017;16(3):356-363. doi:10.1111/jocd.12330